ReviewVaccine2023

Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022.

Emily Jane Woo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.